Summary of reported outcomes of included studies
| Study design | BA | CCT | Cohort | RCT | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary and secondary outcome measures | Total | Choi et al15 | Crane et al30 | French et al17 | Grant et al16 | Han et al18 | Imperato et al20 | Imperato et al19 | Patel and Vinson21 | Richardson et al22 | Rogg et al23 | Shetty et al24 | Soremekun et al 2012a25 | Soremekun et al 2012b26 | Soremekun et al27 | Travers and Lee28 | White et al29 | Partovi et al39 | Terris et al38 | Asha and Ajam 31 | Baumann et al33 | Burstrom et al32 | Cheng et al34 | Davis et al37 | Holroyd et al35 | Subash et al36 |
| LOS (min) | 19 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||
| Waiting time (min) | 13 | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||||||
| LWBS (%)* | 14 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||||
| LWTC (%) | 4 | X | X | X | X | |||||||||||||||||||||
| Patient satisfaction | 6 | X | X | X | X | X | X | |||||||||||||||||||
| Mortality (%) | 2 | X | X | |||||||||||||||||||||||
| Re-attendance (%) | 3 | X | X | X | ||||||||||||||||||||||
*In three American studies, LWBS is defined as the proportion of patients who left without being seen as well as those who left without their treatment complete. 18 ,20 ,33
BA, before and after study; CCT, clinical controlled trail; LOS, length of stay; LWBS, left without being seen; LWTC, left without treatment complete; RCT, randomised controlled trial.